Experimental blood thinner apixaban is 50% better than aspirin at preventing strokes, study says
Researchers have prematurely terminated a clinical trial of an experimental blood thinner because the drug proved to be much better than aspirin at preventing strokes caused by atrial fibrillation, researchers said Tuesday. The drug, called apixaban, is one of three new drugs that are expected to compete against the widely used blood thinner warfarin in a market that is thought to be worth at …

Read more on Baltimore Sun

Tags:,,,,,,,,,,

Comments are closed.


SEO Powered By SEOPressor